IOL CHEMICALS & PHARM. | SYNCOM FORMULATIONS | IOL CHEMICALS & PHARM./ SYNCOM FORMULATIONS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | 49.7 | 27.7% | View Chart |
P/BV | x | 1.6 | 5.1 | 30.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SYNCOM FORMULATIONS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SYNCOM FORMULATIONS Mar-23 |
IOL CHEMICALS & PHARM./ SYNCOM FORMULATIONS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 13 | 4,128.5% | |
Low | Rs | 272 | 5 | 5,982.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 2.4 | 15,829.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0.2 | 11,099.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.3 | 12,055.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 2.7 | 9,429.1% | |
Shares outstanding (eoy) | m | 58.71 | 940.00 | 6.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.7 | 29.1% | |
Avg P/E ratio | x | 17.1 | 41.1 | 41.5% | |
P/CF ratio (eoy) | x | 12.8 | 33.5 | 38.2% | |
Price / Book Value ratio | x | 1.6 | 3.2 | 48.9% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 8,249 | 287.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 244 | 688.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 2,243 | 988.7% | |
Other income | Rs m | 256 | 146 | 175.4% | |
Total revenues | Rs m | 22,427 | 2,389 | 939.0% | |
Gross profit | Rs m | 2,257 | 199 | 1,133.3% | |
Depreciation | Rs m | 462 | 45 | 1,017.0% | |
Interest | Rs m | 165 | 34 | 484.3% | |
Profit before tax | Rs m | 1,887 | 266 | 709.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 65 | 761.5% | |
Profit after tax | Rs m | 1,391 | 201 | 693.2% | |
Gross profit margin | % | 10.2 | 8.9 | 114.6% | |
Effective tax rate | % | 26.2 | 24.5 | 107.3% | |
Net profit margin | % | 6.3 | 8.9 | 70.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,817 | 532.0% | |
Current liabilities | Rs m | 5,025 | 1,132 | 444.1% | |
Net working cap to sales | % | 20.9 | 30.6 | 68.5% | |
Current ratio | x | 1.9 | 1.6 | 119.8% | |
Inventory Days | Days | 43 | 231 | 18.7% | |
Debtors Days | Days | 8 | 1,229 | 0.7% | |
Net fixed assets | Rs m | 11,017 | 1,961 | 561.7% | |
Share capital | Rs m | 587 | 940 | 62.5% | |
"Free" reserves | Rs m | 14,490 | 1,620 | 894.4% | |
Net worth | Rs m | 15,077 | 2,560 | 588.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 3,778 | 547.4% | |
Interest coverage | x | 12.5 | 8.8 | 141.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 180.6% | |
Return on assets | % | 7.5 | 6.2 | 121.1% | |
Return on equity | % | 9.2 | 7.8 | 117.7% | |
Return on capital | % | 13.6 | 11.7 | 116.2% | |
Exports to sales | % | 26.7 | 63.3 | 42.3% | |
Imports to sales | % | 0 | 7.7 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 1,419 | 417.9% | |
Imports (cif) | Rs m | NA | 172 | 0.0% | |
Fx inflow | Rs m | 5,930 | 1,419 | 417.9% | |
Fx outflow | Rs m | 6,052 | 204 | 2,960.3% | |
Net fx | Rs m | -122 | 1,215 | -10.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 105 | 1,161.3% | |
From Investments | Rs m | -1,200 | -450 | 266.9% | |
From Financial Activity | Rs m | -41 | 350 | -11.7% | |
Net Cashflow | Rs m | -18 | 6 | -318.3% |
Indian Promoters | % | 48.2 | 50.6 | 95.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 2,125.0% | |
FIIs | % | 1.4 | 0.1 | 1,750.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.4 | 104.8% | |
Shareholders | 130,003 | 325,761 | 39.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | SYNCOM FORMULATIONS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.74% | 1.16% | 0.27% |
1-Month | 6.42% | 20.38% | 2.36% |
1-Year | -2.02% | 130.79% | 55.86% |
3-Year CAGR | -12.70% | 39.01% | 15.15% |
5-Year CAGR | 16.96% | 68.05% | 19.59% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the SYNCOM FORMULATIONS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of SYNCOM FORMULATIONS the stake stands at 50.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of SYNCOM FORMULATIONS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
SYNCOM FORMULATIONS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of SYNCOM FORMULATIONS.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.